EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Prevalence and Clinical Characteristics of MYO3A-Associated Hearing Loss in 15,684 Hearing Loss Patients

Karuna Maekawa, Shin-Ya Nishio iD, Hiromitsu Miyazaki, Yoko Ohta, Naoki Oishi iD, Misato Kasai, Ai Yamamoto, Mayuri Okami, Koichiro Wasano iD, Akihiro Sakai, Shin-Ichi Usami iD

Genes · 2025

DOI: 10.3390/genes16010092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Karuna Maekawa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hearing Implant Sciences, Shinshu University School of Medicine, Matsumoto 390-8621, Japan. Hauptthemen laut MEDLINE: Myosin Type III, Myosin Heavy Chains, Hearing Loss, Sensorineural. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Ministry of Health, Labor and Welfare of Japan, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: MYO3A belongs to the unconventional myosin superfamily, and the myosin IIIa protein localizes on the tip of the stereocilia of vestibular and cochlear hair cells. Deficiencies in MYO3A have been reported to cause the deformation of hair cells into abnormally long stereocilia with an increase in spacing. MYO3A is a rare causative gene of autosomal recessive sensorineural hearing loss (DFNB30), with only 13 cases reported to date. In this study, we aimed to elucidate the phenotypes caused by MYO3A variations.

Methods

Massively parallel DNA sequencing was performed on 15,684 Japanese hearing loss patients (mean age 27.5 ± 23.1 years old, 6574 male, 8612 female and 498 patients for whom information was unavailable), identifying nine candidate patients with MYO3A variants.

Results

We identified eight causative MYO3A variants by massively parallel DNA sequencing, including six novel variants, and reported nine individuals possessing MYO3A gene variants, which is the largest group of non-related patients yet to be detected. Our findings confirmed that MYO3A variants cause progressive hearing loss, with its onset varying from birth to the second decade, eventually leading to severe-to-profound hearing loss.

Conclusions

We clarified that patients with MYO3A gene variants present with late-onset, progressive hearing loss. Our findings have enabled us to predict the outcomes of hearing loss in patients with candidate MYO3A gene variants and to provide intervention in a timely manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myosin Type IIIMyosin Heavy ChainsHearing Loss, SensorineuralHumansMaleFemaleAdultAdolescentYoung AdultChildMiddle AgedChild, PreschoolMutationPrevalenceInfantPhenotypeHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

DFNB30MYO3Alate-onset hearing lossnon-syndromic hearing lossprogressive hearing loss

Substanzen

Myosin Type IIIMyosin Heavy ChainsMYO3A protein, human

Autor:innen und Institutionen

  • Department of Hearing Implant Sciences, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
  • Department of Otolaryngology-Head and Neck Surgery, Tohoku University School of Medicine, Sendai 980-8575, Japan.
  • Department of Otorhinolaryngology-Head and Neck Surgery, Tokyo Medical University, Tokyo 160-0023, Japan.
  • Department of Otorhinolaryngology-Head and Neck Surgery, Keio University School of Medicine, Tokyo 160-8582, Japan.
  • Department of Otorhinolaryngology, Juntendo University, Tokyo 113-8421, Japan.
  • Department of Otorhinolaryngology, Tokai University School of Medicine, Isehara 259-1193, Japan.

ORCID-Profile: Shin-Ya Nishio, Naoki Oishi, Koichiro Wasano, Shin-Ichi Usami

Förderung

  • Wellcome Trust
  • Ministry of Health, Labor and Welfare of Japan
  • Japan Agency for Medical Research and Development
  • Health and Labor Sciences Research Grant for Research on Rare and Intractable Diseases and Comprehensive Research on Disability Health and Welfare from the Min…
  • Grants-in-Aid from the Japan Agency for Medical Research and Development (AMED)

Zitieren

APA

Maekawa, K., Nishio, S. Y., Miyazaki, H., Ohta, Y., Oishi, N., Kasai, M., Yamamoto, A., Okami, M., Wasano, K., Sakai, A., & Usami, S. I. (2025). The Prevalence and Clinical Characteristics of MYO3A-Associated Hearing Loss in 15,684 Hearing Loss Patients. Genes. https://doi.org/10.3390/genes16010092

Vancouver

Maekawa K, Nishio SY, Miyazaki H, Ohta Y, Oishi N, Kasai M, et al. The Prevalence and Clinical Characteristics of MYO3A-Associated Hearing Loss in 15,684 Hearing Loss Patients. Genes. 2025. doi:10.3390/genes16010092

BibTeX
@article{Maekawa2025,
  author = {Maekawa, Karuna and Nishio, Shin-Ya and Miyazaki, Hiromitsu and Ohta, Yoko and Oishi, Naoki and Kasai, Misato and Yamamoto, Ai and Okami, Mayuri and Wasano, Koichiro and Sakai, Akihiro and Usami, Shin-Ichi},
  title = {The Prevalence and Clinical Characteristics of MYO3A-Associated Hearing Loss in 15,684 Hearing Loss Patients},
  journal = {Genes},
  year = {2025},
  doi = {10.3390/genes16010092}
}
Kostenlos starten →